Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.1440
-0.0090
(-5.88%)
At close: February 28 at 8:08:56 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-100,016
-109,707
-123,065
-99,540
-57,364
Investing Cash Flow
1,949
37,337
67,185
-52,653
46,664
Financing Cash Flow
43,156
43,462
131,045
70,511
142,953
End Cash Position
60,394
141,645
170,553
95,388
177,070
Income Tax Paid Supplemental Data
--
--
--
--
7
Interest Paid Supplemental Data
5,281
4,552
3,408
3,191
1,505
Capital Expenditure
--
-272
-1,241
-1,245
-3,336
Issuance of Capital Stock
--
43,270
119,761
70,337
102,273
Issuance of Debt
--
--
--
--
39,619
Repayment of Debt
-3
-65
-291
-265
-241
Repurchase of Capital Stock
--
--
-81
--
--
Free Cash Flow
-100,054
-109,979
-124,306
-100,785
-60,700
12/31/2020 - 3/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8AW0.MU Ocean Biomedical Inc
0.0965
-3.50%
0M4.F Mersana Therapeutics, Inc.
0.4243
-1.94%
0M4.SG Mersana Therapeutics Inc
0.4769
-1.22%
AT20.F Atara Biotherapeutics, Inc.
6.55
-5.76%
0M4.DU Mersana Therapeutics Inc
0.4706
-5.35%
8AW0.BE Ocean Biomedical Inc
0.0945
-2.07%
8AW0.F Ocean Biomedical, Inc.
0.0860
-3.37%
8AW0.SG Ocean Biomedical Inc
0.0915
+0.55%
NV4.F Cellectar Biosciences, Inc.
0.2800
+6.87%
NV4.MU Cellectar Biosciences Inc
0.2880
+4.35%